TFC Financial Management’s Unicycive Therapeutics UNCY Stock Holding History
Bought
Maintained
Sold
Other funds holding UNCY
TFC Financial Management's UNCY Position: Q3 2026 in Review
TFC Financial Management held its Unicycive Therapeutics (UNCY) position steady in Q3 2026 at 300 shares worth $1.41K. The position accounts for ﹤0.01% of the portfolio, ranked #619.
TFC Financial Management first reported a position in UNCY in Q3 2025 and has held it in 5 quarters since. The position peaked at $1.97K in Q1 2026. 95 funds tracked by Wall St. Rank hold UNCY as of Q3 2026.
- TFC Financial Management held 300 shares of Unicycive Therapeutics worth $1.41K as of Q3 2026.
- TFC Financial Management left its Unicycive Therapeutics share count unchanged in Q3 2026.
- Unicycive Therapeutics made up ﹤0.01% of TFC Financial Management's portfolio in Q3 2026, its #619 holding.
- TFC Financial Management first reported a position in Unicycive Therapeutics in Q3 2025 and has held it in 5 quarters since.
- TFC Financial Management's Unicycive Therapeutics position peaked at $1.97K in Q1 2026.
- 95 funds tracked by Wall St. Rank held Unicycive Therapeutics as of Q3 2026.
Based on TFC Financial Management's 13F filing for Q3 2026, filed 26 Oct 2026.